Chun Wel Lin

769 citations

25 papers · 567 indexed · h-index 13

Co-authors: Curtis M. Tyree Michael A. Stashko Kazumi Shiosaki Michael J. Coghlan Steven W. Elmore John K. Pratt Benjamin C. Lane Denise M. Wilcox
Topics: Receptor Mechanisms and Signaling (10 papers)Neuropeptides and Animal Physiology (7 papers)Estrogen and related hormone effects (5 papers)
Cited by: Endocrinology, Diabetes and Metabolism Cellular and Molecular Neuroscience Organic Chemistry
Journals: Biochemistry Brain Research Journal of Medicinal Chemistry
Partner nations: United States United Kingdom Finland

In The Last Decade

Chun Wel Lin

24 papers receiving 546 citations

Peers

Countries citing papers authored by Chun Wel Lin

Since Specialization

Citations

This map shows the geographic impact of Chun Wel Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun Wel Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun Wel Lin more than expected).

Fields of papers citing papers by Chun Wel Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun Wel Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun Wel Lin. The network helps show where Chun Wel Lin may publish in the future.

Co-authorship network of co-authors of Chun Wel Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chun Wel Lin. A scholar is included among the top collaborators of Chun Wel Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun Wel Lin. Chun Wel Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: Side chain exploration 2006 ·Bioorganic & Medicinal Chemistry Letters ·Bo Liu,Mei Liu,Zhili Xin,Hongyu Zhao,Michael D. Serby,(unknown),Lissa T.J. Nelson,Bruce G. Szczepankiewicz,Wiweka Kaszubska,Verlyn G. Schaefer,Hugh D. Falls,Chun Wel Lin,Christine A. Collins,Hing L. Sham,Gang Liu	11
2	Biaryl amide glucagon receptor antagonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Ravi Kurukulasuriya,Bryan K. Sorensen,J. T. Link,(unknown),Hwan-Soo Jae,(unknown),(unknown),(unknown),Chun Wel Lin,(unknown),Andrew Adler,Christine A. Collins	21
3	Cloning and characterization of the glucagon receptor from cynomologous monkey 2004 ·Peptides ·Teresa McNally,(unknown),Terry M. Pederson,(unknown),Stevan W. Djurić,Christine A. Collins,Chun Wel Lin,Regina M. Reilly	0
4	Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators 2004 ·Bioorganic & Medicinal Chemistry Letters ·Steven W. Elmore,John K. Pratt,Michael J. Coghlan,Yue Mao,(unknown),David D. Anderson,Michael A. Stashko,Chun Wel Lin,Douglas L. Falls,Masaki Nakane,Loan Miller,Curtis M. Tyree,Jeffrey N. Miner,Ben Lane	41
5	Putting Thought to Paper: A μARCS Protease Screen 2003 ·SLAS DISCOVERY ·Duncan R. Groebe,(unknown),Terry M. Pederson,Jill E. Clampit,Stevan W. Djurić,James M. Trevillyan,Chun Wel Lin,David J. Burns,Usha Warrior	4
6	trans-Activation and Repression Properties of the Novel Nonsteroid Glucocorticoid Receptor Ligand 2,5-Dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and Its Four Stereoisomers 2002 ·Molecular Pharmacology ·Chun Wel Lin,Masaki Nakane,(unknown),(unknown),Jane Kuk,Loan Miller,(unknown),Curtis M. Tyree,Jeffrey N. Miner,John F. Rosen,Philip R. Kym,(unknown),George Carter,Ben Lane	43
7	Nonsteroidal Selective Glucocorticoid Modulators: the Effect of C-5 Alkyl Substitution on the Transcriptional Activation/Repression Profile of 2,5-Dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines 2001 ·Journal of Medicinal Chemistry ·Steven W. Elmore,Michael J. Coghlan,David D. Anderson,John K. Pratt,(unknown),(unknown),Michael A. Stashko,Chun Wel Lin,Curtis M. Tyree,(unknown),Peer B. Jacobson,Denise M. Wilcox,Benjamin C. Lane	94
8	ChemInform Abstract: trans‐2,6‐, 3,6‐ and 4,6‐Diaza‐5,6,6a,7,8,12b‐hexahydrobenzo[c]phenanthrene‐10,11‐diols as Dopamine Agonists. 1999 ·ChemInform ·Yu Gu,Erol K. Bayburt,(unknown),Chun Wel Lin,Kazumi Shiosaki	1
9	Induced expression of neuronal membrane attack complex and cell death by Alzheimer's β-amyloid peptide 1998 ·Brain Research ·Yong Shen,(unknown),Chi‐Ming Lee,Seppo Meri,Kazumi Shiosaki,Chun Wel Lin	38
10	Minor Structural Differences in Boc-CCK-4 Derivatives Dictate Affinity and Selectivity for CCK-A and CCK-B Receptors 1997 ·Journal of Medicinal Chemistry ·Kazumi Shiosaki,Chun Wel Lin,Hana Kopecka,Bruce R. Bianchi,Thomas R. Miller,Michael A. Stashko,David G. Witte	2
11	Human astrocytoma U138MG cells express predominantly type-A endothelin receptor 1996 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Jinshyun R. Wu‐Wong,William J. Chiou,Scott R. Magnuson,Bruce R. Bianchi,Chun Wel Lin	14
12	(5aR,11bS)-4,5,5a,6,7,11b-Hexahydro-2-propyl-3-thia-5-azacyclopent-1-ena[c]phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintain behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431) 1995 ·Journal of Medicinal Chemistry ·(unknown),(unknown),Stanley DiDomenico,Karen E. Asin,Donald R. Britton,Chun Wel Lin,Michael Williams,Kazumi Shiosaki	51
13	Amino acid-derived piperidides as novel CCKB ligands with anxiolytic-like properties 1995 ·Bioorganic & Medicinal Chemistry Letters ·Mark W. Holladay,Michael J. Bennett,(unknown),(unknown),James F. Kerwin,Michael A. Stashko,Thomas R. Miller,Alyssa B. O'Neill,Alex M. Nadzan,Jorge D. Brioni,Chun Wel Lin	5
14	Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus 1994 ·Journal of Medicinal Chemistry ·Richard L. Elliott,Hana Kopecka,Michael J. Bennett,(unknown),R.G. Craig,Chun Wel Lin,Bruce R. Bianchi,Thomas R. Miller,David G. Witte	9
15	Double bond isosteres of the peptide bond: Synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs 1993 ·Bioorganic & Medicinal Chemistry ·Youe‐Kong Shue,Michael D. Tufano,George M. Carrera,Hana Kopecka,(unknown),Mark W. Holladay,Chun Wel Lin,David G. Witte,Thomas R. Miller,(unknown),Alex M. Nadzan	6
16	Peripheral cholecystokinin type A receptors mediate oxytocin secretion in vivo 1993 ·Regulatory Peptides ·Thomas R. Miller,(unknown),David G. Witte,Chun Wel Lin	10
17	Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells 1992 ·Peptides ·David G. Witte,Alex M. Nadzan,Jean Martínez,Marc Rodriguez,Chun Wel Lin	13
18	Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N.epsilon.)-amide residues 1992 ·Journal of Medicinal Chemistry ·Kazumi Shiosaki,Chun Wel Lin,Hana Kopecka,(unknown),Bruce R. Bianchi,Thomas R. Miller,(unknown),Michael A. Stashko,Alex M. Nadzan	6
19	Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists 1989 ·Journal of Medicinal Chemistry ·James F. Kerwin,Alex M. Nadzan,Hana Kopecka,Chun Wel Lin,Thomas R. Miller,David G. Witte,Stanley K. Burt	25
20	[3H]Dihydroergocryptine binding to bovine striatal membranes defined by a low d-butaclamol concentration 1981 ·Biochemical Pharmacology ·Chun Wel Lin,Saul Maayani,Sherwin Wilk	2

About Chun Wel Lin

Chun Wel Lin is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Endocrinology, Diabetes and Metabolism, having authored 25 papers that have together received 567 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (10 papers), Neuropeptides and Animal Physiology (7 papers) and Estrogen and related hormone effects (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (123 citations), Cellular and Molecular Neuroscience (123 citations) and Organic Chemistry (178 citations). Chun Wel Lin has collaborated with scholars based in United States, United Kingdom and Finland. Frequent co-authors include Curtis M. Tyree, Michael A. Stashko, Kazumi Shiosaki, Michael J. Coghlan, Steven W. Elmore, John K. Pratt, Benjamin C. Lane, Denise M. Wilcox, Peer B. Jacobson and David G. Witte. Their work appears in journals such as Biochemistry, Brain Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact